Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | TAS2R14 | Q9NYV8 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | HTT | P42858 | 3/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | AGER | Q15109 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | CNR2 | P34972 | 4/20 | 0.43 |
| ▸ | BACE1 | P56817 | 2/20 | 0.43 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.43 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.43 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28211577 | 0.79 | TAS2R14 (0.65) | GLATAS2R14MAPTNPSR1AGER | |
| SCHEMBL28292240 | 0.77 | GAA (0.46) | MAPTHTTKMT2AKDM4EMEN1 | |
| SCHEMBL8778760 | 0.77 | GAA (0.46) | MAPTHTTKMT2AKDM4EMEN1 | |
| SCHEMBL9187490 | 0.76 | GLA (0.53) | GLATAS2R14MAPTHTTAGER | |
| SCHEMBL30121315 | 0.76 | GAA (0.54) | MAPTKMT2AAGERLMNAMCOLN3 | |
| SCHEMBL6396982 | 0.75 | GAA (0.45) | MAPTHTTNPSR1KMT2AAGER | |
| SCHEMBL2780461 | 0.75 | GAA (0.45) | MAPTHTTKMT2ALMNAKDM4E | |
| SCHEMBL12215061 | 0.75 | MAPT (0.48) | GLATAS2R14MAPTHTTNPSR1 | |
| SCHEMBL4727639 | 0.75 | CA2 (0.45) | LMNACNR2GAA | |
| SCHEMBL10692733 | 0.74 | GLA (0.59) | GLATAS2R14MAPTHTTAGER |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1493566-A | Preparation method of 1,4,7,10,13-penta azacyclopentadecane | 江苏省原子医学研究所 | 2004-05-05 | — | — | CN | disclosed |
| US-5681543-A | Polymer-bonded complexing agents and pharmaceutical agents containing them for MRI | SHERING AKTIENGESELLSCHAFT (DE) | 1997-10-28 | — | — | US | disclosed |
| US-5681544-A | Polymer-bonded complexing agents, their complexes and conjugates, processes for their production and pharmaceutical agents containing them | SCHERING AKTIENGESELLSCHAFT (DE) | 1997-10-28 | — | — | US | disclosed |
| EP-0331616-B1 | Polymer-bonded complexe builders, their complexes, process for their preparation and pharmaceutical agents containing the same | SCHERING AG (DE) | 1995-11-08 | — | — | EP | disclosed |
| EP-0305320-B1 | MULTINUCLEIC SUBSTITUTED COMPLEXANTS, COMPLEXES AND COMPLEX SALTS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL AGENTS CONTAINING THEM | SCHERING AKTIENGESELLSCHAFT (DE) | 1992-09-23 | — | — | EP | disclosed |
| EP-0355097-A1 | SUBSTITUTED CYCLIC COMPLEX-FORMING SUBSTANCES, COMPLEXES AND COMPLEX SALTS, PROCESS FOR MANUFACTURING SAME, AND PHARMACEUTICAL AGENTS WHICH CONTAIN THEM | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-02-28 | — | — | EP | disclosed |
| EP-0305320-A2 | Multinucleic substituted complexants, complexes and complex salts, process for their preparation and pharmaceutical agents containing them | SCHERING AKTIENGESELLSCHAFT (DE) | 1989-03-01 | — | — | EP | disclosed |
| WO-1988008422-A1 | SUBSTITUTED CYCLIC COMPLEX-FORMING SUBSTANCES, COMPLEXES AND COMPLEX SALTS, PROCESS FOR MANUFACTURING SAME, AND PHARMACEUTICAL AGENTS WHICH CONTAIN THEM | SCHERING AKTIENGESELLSCHAFT (DE) | 1988-11-03 | — | — | WO | disclosed |